To begin an activity,
click the title of the program you wish to view.

Blood Glucose Monitoring
Click on The Title to Enter the Activity

The goal of this educational activity is to increase awareness of the role of blood glucose monitoring in the management of diabetes and to provide information that will improve the prognosis of patients with diabetes

This educational activity is designed for pharmacists, nurses, and dietitians who are involved with patient education and counseling

  • Pharmacists: .125 CEUs
  • Registered Nurses: 1.5 contact hours
  • Dietitians: 1.0 Continuing Professional Education Unit

Management of Hemophilia and Other Bleeding Disorders
Click on The Title to Enter the Activity

This educational program provides pharmacists and nurses with a review of the pathophysiology of hemophilia and other bleeding disorders as well as an update on the newest treatment options available.

Included in this program is a description of the deficiencies in the coagulation cascade that affect patients with hemophilia A or B, and a discussion of inhibitor development and how inhibitors are diagnosed. Additionally, information is provided on current treatment options for hemophilia as well as for other bleeding disorders.

This continuing education activity is provided by an unrestricted educational grant from Novo Nordisk Pharmaceuticals, Inc.

This activity offers CE credit for pharmacists and registered nurses.

  • Pharmacists: .25 CEUs
  • Registered Nurses: 1.8 contact hours

Insulin Delivery Systems for the Management of Diabetes
Click on The Title to Enter the Activity

The choice of insulin delivery systems is currently quite broad, with new options under development. Knowledge of the available and potential future options for insulin delivery is important for all members of the diabetes management team.

This monograph will provide pharmacists and nurses with information on the importance of glycemic control and knowledge of a variety of methods of insulin delivery so that they may guide patients with diabetes in selecting the most suitable delivery method.

This continuing education activity is provided by an unrestricted educational grant from Novo Nordisk Pharmaceuticals, Inc.

This activity offers CE credit for pharmacists and registered nurses.

  • Pharmacists: .10 CEUs
  • Registered Nurses: 1.2 contact hours

Diabetic Ketoacidosis in the Adult Patient
Click on The Title to Enter the Activity

DKA is a life-threatening complication of diabetes that is caused by relative or absolute insulin deficiency, which results in hyperglycemia, ketonemia, dehydration, electrolyte imbalances, and acidosis. Treatment protocols for adults generally advocate a more rapid and aggressive reversal of DKA than is advised for children. DKA consumes a significant proportion of all direct medical costs for adults and children with type 1 diabetes. The management of DKA requires a full complement of hospital, emergency, and intensive care services. In the United States, more than 100,000 individuals are hospitalized each year for DKA and the mortality rate is 2% to 5%.

Most cases of DKA can be prevented by using an effective diabetes management plan that includes patient self-care. Early identification of precipitating signs and symptoms and prompt, appropriate intervention can reduce the frequency of DKA episodes that result in a medical emergency.

The healthcare team must stay informed about the recent developments in diabetes care and have the necessary clinical skills to prevent and manage DKA episodes. Through good self-management and intensive glycemic control, the incidence, morbidity, and mortality of DKA can be reduced.

This continuing education activity is provided by an unrestricted educational grant from Novo Nordisk Pharmaceuticals, Inc.

This activity offers CE credit for pharmacists and registered nurses.

  • Pharmacists: .18 CEUs
  • Registered Nurses: 2.8 contact hours

This activity is designed to enhance the healthcare professional's knowledge and understanding of the management of growth hormone deficiency in children. It is intended for pharmacists, nurses, and certified case managers who work with children referred for evaluation and treatment of short stature. In addition to a review of the structure, regulation and physiologic actions of growth hormone, this program will describe the diagnosis and treatment of growth hormone deficiency.

This continuing education activity is supported by an unrestricted educational grant from Novo Nordisk Pharmaceuticals, Inc.

This activity offers CE credit for pharmacists, nurses, and case managers.

    • Pharmacists: .1 CEUs
    • Registered Nurses: 1.2 contact hours
    • Case Managers : 1.0 clock hour

Insulin Delivery Systems
Click on The Title to Enter the Activity

This activity is designed to enhance the healthcare professional's knowledge and understanding of insulin delivery systems in the management of diabetes. It is intended for pharmacists, nurses, and dietitians who work with or anticipate working with patients with diabetes who may require insulin. Discussed in the activity are a review of key findings of the Diabetes Control and Complications Trial and the United Kingdom Prospective Diabetes Study; current options for insulin delivery; a comparison of traditional vial and syringe insulin administration to other insulin delivery systems; and insulin delivery systems in research and development.

This continuing education activity is supported by an unrestricted educational grant from Novo Nordisk Pharmaceuticals, Inc.

This activity offers CE credit for pharmacists, nurses, and dietitians:

      • Pharmacists: .1 CEUs
      • Registered Nurses: 1.2 contact hours
      • Dietitians: 1.0 CPEUs

The Basics of Continuous Subcutaneous Insulin Infusion Therapy
Click on The Title to Enter the Activity

This continuing education monograph is designed for nurses and pharmacists who treat patients with diabetes and wish to expand their knowledge of insulin therapy and continuous subcutaneous insulin infusion (CSII).

Described in the activity are the basic mechanism of CSII therapy, the intent and indications, and the process for selecting, training, and initiating patients to CSII therapy. Also discussed are the risks and benefits associated with CSII therapy, the types of insulin used, and the material, financial, and psychosocial resources necessary for successful CSII therapy.

This continuing education activity is supported by an unrestricted educational grant from Novo Nordisk Pharmaceuticals, Inc.

This activity offers CE credit for pharmacists:

      • Pharmacists: .2 CEUs

Managing Diabetes with Oral Antidiabetic Agents

This activity is designed to enhance the healthcare professional's knowledge and understanding of treatment options that may be considered when implementing oral medications in the stepped care approach to type 2 diabetes. It is intended for pharmacists, nurses, and dietitians who are involved in the education and counseling of patients with type 2 diabetes.

Discussed in the activity are special considerations to review with the patient who is taking oral antidiabetic medications and the mechanism of action of oral medications available to treat type 2 diabetes.

This program is supported through an unrestricted educational grant from Novo Nordisk Pharmaceuticals, Inc.

This activity offers CE credit for pharmacists, nurses, and dietitians:

      • Pharmacists: .1 CEUs
      • Registered Nurses: 1.2 Contact Hours
      • Dietitians: 1.0 CPEUs

This monograph has been designed to enhance the healthcare professional's knowledge and understanding of new insulin products and diabetes treatment strategies. It is intended for pharmacists and dietitians who work with or anticipate working with patients with diabetes who may require insulin.

Discussed in the program are the impact of the disease, insulin formulations, insulin analogs, dosing regimens, and available alternatives for insulin administration. The benefits of tight glycemic control and techniques for minimizing problems associated with insulin therapy are identified and described.

This program is supported through an unrestricted educational grant from Novo Nordisk Pharmaceuticals, Inc.

This activity offers CE credit for pharmacists:

      • Pharmacists: .15 CEU

 

 

 
All product information on this site is for U.S. residents only.
Legal Disclaimer & Copy Rights

Novo Nordisk Pharmaceuticals Inc.